Page last updated: 2024-10-20

uric acid and Cirrhosis, Liver

uric acid has been researched along with Cirrhosis, Liver in 75 studies

Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.

Research Excerpts

ExcerptRelevanceReference
"To assess the degree of oxidative stress, we measured plasma ubiquinone-10 percentage (%CoQ-10) in total amounts of ubiquinone-10 in patients with chronic active hepatitis, liver cirrhosis, and hepatocellular carcinoma, and in age-matched control subjects, %CoQ-10 values were 12."7.70Plasma ubiquinone to ubiquinol ratio in patients with hepatitis, cirrhosis, and hepatoma, and in patients treated with percutaneous transluminal coronary reperfusion. ( Yamamoto, Y; Yamashita, S, 1999)
"We analyzed the serum anion gap (AG = sodium plus potassium minus chloride plus bicarbonate, N = 11-21 mEq/l), serum uric acid and urea concentrations in hyponatremia of various origins."7.69Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia. ( Brimioulle, S; Coffernils, M; Decaux, G; Namias, B; Prospert, F; Schlesser, M; Soupart, A, 1994)
"The disposition of benzbromarone and its uric acid lowering effect were investigated in 8 patients with compensated liver cirrhosis in order to obtain evidence whether dose requirements differ from subjects with normal liver function."7.69Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites? ( de Vries, JX; Pfleilschifter, V; Raedsch, R; von Bubnoff, A; Walter-Sack, I, 1995)
"Uric acid is an endogenous danger signal and activator of the inflammasome, and has been independently associated with an increased risk of cirrhosis."5.51Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD). ( Aller, R; Ampuero, J; Andrade, RJ; Aspichueta, P; Buque, X; Burgos-Santamaría, D; Fernández Rodríguez, CM; Gómez-Camarero, J; Gutiérrez García, ML; Hernández-Guerra, M; Latorre, M; Martín-Mateos, RMª; Romero-Gómez, M; Rosales, JM, 2019)
" The changes in serum uric acid (SUA) levels in chronic hepatitis C patients who receive antivirals are not well understood."3.96Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents. ( Chen, SC; Chuang, WL; Dai, CY; Hou, NJ; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Jang, TY; Liang, PC; Lin, YH; Lin, ZY; Tsai, PC; Yeh, ML; Yu, ML, 2020)
"High serum uric acid levels increase the risk of liver steatosis in lean patients."3.96Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality. ( Eigenbauer, E; Forstner, B; Mandorfer, M; Muckenhuber, M; Paternostro, R; Pfisterer, N; Reiberger, T; Scheiner, B; Scheuba, K; Trauner, M; Unger, LW, 2020)
"To assess the degree of oxidative stress, we measured plasma ubiquinone-10 percentage (%CoQ-10) in total amounts of ubiquinone-10 in patients with chronic active hepatitis, liver cirrhosis, and hepatocellular carcinoma, and in age-matched control subjects, %CoQ-10 values were 12."3.70Plasma ubiquinone to ubiquinol ratio in patients with hepatitis, cirrhosis, and hepatoma, and in patients treated with percutaneous transluminal coronary reperfusion. ( Yamamoto, Y; Yamashita, S, 1999)
"We analyzed the serum anion gap (AG = sodium plus potassium minus chloride plus bicarbonate, N = 11-21 mEq/l), serum uric acid and urea concentrations in hyponatremia of various origins."3.69Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia. ( Brimioulle, S; Coffernils, M; Decaux, G; Namias, B; Prospert, F; Schlesser, M; Soupart, A, 1994)
"The disposition of benzbromarone and its uric acid lowering effect were investigated in 8 patients with compensated liver cirrhosis in order to obtain evidence whether dose requirements differ from subjects with normal liver function."3.69Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites? ( de Vries, JX; Pfleilschifter, V; Raedsch, R; von Bubnoff, A; Walter-Sack, I, 1995)
"In a population of 27 consecutive patients with liver cirrhosis, systemic hemodynamics were investigated and correlated to uric acid concentrations, fractional uric acid excretion, and creatinine clearances."3.67Hypouricemia in cirrhosis reflects hemodynamic alterations. ( Decaux, G; Mols, P; Naeije, R; Reding, P, 1984)
"By central venous catheterization, 6 control persons, 7 patients with liver cirrhosis and 6 patients with diabetes mellitus were infused for 48 h with a 20% (w/v) mixture of glucose/xylitol (1:1)."3.66[Carbohydrate infusion in internal diseases. A comparative study in metabolically healthy, liver diseased and diabetic patients. VI. Infusions of a glucose/xylitol mixture (1:1 ratio) over a 48-hour period]. ( Egberts, EH; Horbach, L; Malchow, H; Müller, PH; Prestele, H; Rittershofer, H; Schmülling, R, 1982)
"Uric acid is a natural antioxidant."2.55Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. ( Ahuja, W; Jaruvongvanich, V; Ungprasert, P; Wijarnpreecha, K, 2017)
"Nonalcoholic fatty liver disease (NAFLD), tightly linked to the metabolic syndrome (MS), has emerged as a leading cause of chronic liver disease worldwide."2.53Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD. ( Fargion, S; Lombardi, R; Pisano, G, 2016)
"NAFLD was assessed using the Fibrosis-4 (Fib-4) index."1.91Improvement in hepatic fibrosis estimated by Fibrosis-4 index in pegloticase treated chronic refractory gout patients. ( Lipsky, PE; Rustgi, VK; Schlesinger, N; Yeo, AE, 2023)
"In this study, type 2 diabetes (T2D), sex, and menopausal status were combined to refine the stratification of obesity regarding the risk of advanced SLD and gain further insight into disease physiopathology."1.91Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort study. ( Baud, G; Bauvin, P; Caiazzo, R; Chatelain, E; Chetboun, M; Gnemmi, V; Lasailly, G; Lefebvre, P; Legendre, B; Leteurtre, E; Marciniak, C; Marot, G; Mathurin, P; Oukhouya-Daoud, N; Pattou, F; Raverdy, V; Staels, B; Vandel, J; Vantyghem, MC; Verkindt, H, 2023)
"This study elucidates the development of liver fibrosis under hyperuricemia."1.56Uric acid induces liver fibrosis through activation of inflammatory mediators and proliferating hepatic stellate cell in mice. ( Arfian, N; Romi, MM; Sari, DCR; Setyaningsih, WAW; Soetoko, AS; Tranggono, U, 2020)
"Uric acid elevation was reported in many systemic diseases and might be elevated during direct antiviral therapy."1.56Efficacy of antiviral therapy in patients with post-hepatitis C liver cirrhosis: is hyperuricaemia a potential adverse effect? ( Abbas, A; Elsayed, A; Hassan, H; Hassnine, A; M Abdelraheem, E, 2020)
"We recruited 1527 adult patients with NAFLD who completed a comprehensive health checkup."1.51The severity of NAFLD is associated with the risk of urolithiasis. ( Qin, S; Wang, J; Wang, S; Wang, X; Xu, Y; Zhang, Y; Zhou, C, 2019)
"Uric acid is an endogenous danger signal and activator of the inflammasome, and has been independently associated with an increased risk of cirrhosis."1.51Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD). ( Aller, R; Ampuero, J; Andrade, RJ; Aspichueta, P; Buque, X; Burgos-Santamaría, D; Fernández Rodríguez, CM; Gómez-Camarero, J; Gutiérrez García, ML; Hernández-Guerra, M; Latorre, M; Martín-Mateos, RMª; Romero-Gómez, M; Rosales, JM, 2019)
"In inactive liver cirrhosis of alcoholic etiology, the concentrations of lactic and uric acids tended toward reduction, however, they were significantly higher than in the group of patients with virus liver lesions."1.27[Diagnostic significance of determining the blood content of lactic and uric acids in chronic liver lesions of alcoholic and viral etiologies]. ( Blok, IuE; Dzhalalov, KD; Loginov, AS, 1985)

Research

Studies (75)

TimeframeStudies, this research(%)All Research%
pre-199043 (57.33)18.7374
1990's9 (12.00)18.2507
2000's4 (5.33)29.6817
2010's6 (8.00)24.3611
2020's13 (17.33)2.80

Authors

AuthorsStudies
Schlesinger, N1
Rustgi, VK1
Yeo, AE1
Lipsky, PE1
Duan, H1
Zhang, R1
Chen, X2
Yu, G1
Song, C1
Jiang, Y2
He, Y2
Wan, H1
Shen, J4
Lv, XT1
Wang, RH1
Liu, XT1
Ye, YJ1
Liu, XY1
Qiao, JD1
Wang, GE1
Fan, WH1
Zhu, T1
Xu, G1
Chen, Y4
Liao, W2
Liang, XS1
Li, CZ1
Shi, A1
Deng, J1
Ma, J1
Yang, L1
Tantai, X1
Wang, Q3
Chang, D1
Wang, J6
Guo, X1
Lu, X1
Shi, H1
Ding, Y1
Wang, Z2
Niu, H1
Deng, Q1
Wang, Y3
Xia, S1
Raverdy, V1
Chatelain, E1
Lasailly, G1
Caiazzo, R1
Vandel, J1
Verkindt, H1
Marciniak, C1
Legendre, B1
Bauvin, P1
Oukhouya-Daoud, N1
Baud, G1
Chetboun, M1
Vantyghem, MC1
Gnemmi, V1
Leteurtre, E1
Staels, B1
Lefebvre, P1
Mathurin, P1
Marot, G1
Pattou, F1
Jang, TY1
Huang, CI1
Yeh, ML1
Liang, PC1
Tsai, PC1
Lin, YH1
Hsieh, MY1
Hou, NJ1
Lin, ZY1
Chen, SC1
Huang, JF1
Dai, CY1
Huang, CF1
Chuang, WL1
Yu, ML1
Unger, LW1
Forstner, B1
Muckenhuber, M1
Scheuba, K1
Eigenbauer, E1
Scheiner, B1
Pfisterer, N1
Paternostro, R1
Trauner, M1
Mandorfer, M1
Reiberger, T1
Sari, DCR1
Soetoko, AS2
Romi, MM1
Tranggono, U1
Setyaningsih, WAW1
Arfian, N1
Lukenda Zanko, V1
Domislovic, V1
Trkulja, V1
Krznaric-Zrnic, I1
Turk-Wensveen, T1
Krznaric, Z1
Filipec Kanizaj, T1
Radic-Kristo, D1
Bilic-Zulle, L1
Orlic, L1
Dinjar-Kujundzic, P1
Poropat, G1
Stimac, D1
Hauser, G1
Mikolasevic, I1
Nguépy Keubo, FR1
Mboua, PC1
Djifack Tadongfack, T1
Fokouong Tchoffo, E1
Tasson Tatang, C1
Ide Zeuna, J1
Noupoue, EM1
Tsoplifack, CB1
Folefack, GO1
Kettani, M1
Bandelier, P1
Huo, J1
Li, H4
Yu, D1
Arulsamy, N1
AlAbbad, S1
Sardot, T1
Lekashvili, O1
Decato, D1
Lelj, F1
Alexander Ross, JB1
Rosenberg, E1
Nazir, H1
Muthuswamy, N1
Louis, C1
Jose, S1
Prakash, J1
Buan, MEM1
Flox, C1
Chavan, S1
Shi, X1
Kauranen, P1
Kallio, T1
Maia, G1
Tammeveski, K1
Lymperopoulos, N1
Carcadea, E1
Veziroglu, E1
Iranzo, A1
M Kannan, A1
Arunamata, A1
Tacy, TA1
Kache, S1
Mainwaring, RD1
Ma, M1
Maeda, K1
Punn, R1
Noguchi, S1
Hahn, S3
Iwasa, Y3
Ling, J2
Voccio, JP2
Kim, Y3
Song, J3
Bascuñán, J2
Chu, Y1
Tomita, M1
Cazorla, M1
Herrera, E1
Palomeque, E1
Saud, N1
Hoplock, LB1
Lobchuk, MM1
Lemoine, J1
Li, X10
Henson, MA1
Unsihuay, D1
Qiu, J1
Swaroop, S1
Nagornov, KO1
Kozhinov, AN1
Tsybin, YO1
Kuang, S1
Laskin, J1
Zin, NNINM1
Mohamad, MN1
Roslan, K1
Abdul Wafi, S1
Abdul Moin, NI1
Alias, A1
Zakaria, Y1
Abu-Bakar, N1
Naveed, A1
Jilani, K1
Siddique, AB1
Akbar, M1
Riaz, M1
Mushtaq, Z1
Sikandar, M1
Ilyas, S1
Bibi, I1
Asghar, A1
Rasool, G1
Irfan, M1
Li, XY1
Zhao, S1
Fan, XH1
Chen, KP1
Hua, W1
Liu, ZM1
Xue, XD1
Zhou, B1
Zhang, S2
Xing, YL1
Chen, MA1
Sun, Y1
Neradilek, MB1
Wu, XT1
Zhang, D2
Huang, W1
Cui, Y1
Yang, QQ1
Li, HW1
Zhao, XQ1
Hossein Rashidi, B1
Tarafdari, A1
Ghazimirsaeed, ST1
Shahrokh Tehraninezhad, E1
Keikha, F1
Eslami, B1
Ghazimirsaeed, SM1
Jafarabadi, M1
Silvani, Y1
Lovita, AND1
Maharani, A1
Wiyasa, IWA1
Sujuti, H1
Ratnawati, R1
Raras, TYM1
Lemin, AS1
Rahman, MM1
Pangarah, CA1
Kiyu, A1
Zeng, C2
Du, H1
Lin, D1
Jalan, D1
Rubagumya, F1
Hopman, WM1
Vanderpuye, V1
Lopes, G1
Seruga, B1
Booth, CM1
Berry, S1
Hammad, N1
Sajo, EA1
Okunade, KS1
Olorunfemi, G1
Rabiu, KA1
Anorlu, RI1
Xu, C2
Xiang, Y1
Xu, X1
Zhou, L2
Dong, X1
Tang, S1
Gao, XC1
Wei, CH1
Zhang, RG1
Cai, Q1
Tong, F1
Dong, JH1
Wu, G1
Dong, XR1
Tang, X1
Tao, F1
Xiang, W1
Zhao, Y2
Jin, L1
Tao, H1
Lei, Y1
Gan, H1
Huang, Y1
Chen, L3
Shan, A1
Zhao, H2
Wu, M2
Ma, Q1
Zhang, E1
Zhang, J3
Li, Y5
Xue, F1
Deng, L1
Liu, L2
Yan, Z2
Meng, J1
Chen, G2
Anastassiadou, M1
Bernasconi, G1
Brancato, A1
Carrasco Cabrera, L1
Greco, L1
Jarrah, S1
Kazocina, A1
Leuschner, R1
Magrans, JO1
Miron, I1
Nave, S1
Pedersen, R1
Reich, H1
Rojas, A1
Sacchi, A1
Santos, M1
Theobald, A1
Vagenende, B1
Verani, A1
Du, L1
Liu, X1
Ren, Y1
Li, J7
Li, P1
Jiao, Q1
Meng, P1
Wang, F2
Wang, YS1
Wang, C3
Zhou, X2
Wang, W1
Wang, S3
Hou, J1
Zhang, A1
Lv, B1
Gao, C1
Pang, D1
Lu, K1
Ahmad, NH1
Wang, L1
Zhu, J2
Zhang, L2
Zhuang, T1
Tu, J1
Zhao, Z1
Qu, Y1
Yao, H1
Wang, X6
Lee, DF1
Wen, L1
Huang, G2
Xie, X1
Zhao, Q1
Hu, W1
Zhang, Y5
Wu, X1
Lu, J2
Li, M1
Li, W2
Wu, W1
Du, F1
Ji, H1
Yang, X2
Xu, Z1
Wan, L1
Wen, Q1
Cho, CH1
Zou, C1
Xiao, Z1
Liao, J1
Su, X1
Bi, Z1
Su, Q1
Huang, H1
Wei, Y2
Gao, Y2
Na, KJ1
Choi, H1
Oh, HR1
Kim, YH1
Lee, SB1
Jung, YJ1
Koh, J1
Park, S1
Lee, HJ1
Jeon, YK1
Chung, DH1
Paeng, JC1
Park, IK1
Kang, CH1
Cheon, GJ1
Kang, KW1
Lee, DS1
Kim, YT1
Pajuelo-Lozano, N1
Alcalá, S1
Sainz, B1
Perona, R1
Sanchez-Perez, I1
Logotheti, S1
Marquardt, S1
Gupta, SK1
Richter, C1
Edelhäuser, BAH1
Engelmann, D1
Brenmoehl, J1
Söhnchen, C1
Murr, N1
Alpers, M1
Singh, KP1
Wolkenhauer, O1
Heckl, D1
Spitschak, A1
Pützer, BM1
Liao, Y1
Cheng, J1
Kong, X1
Li, S1
Zhang, M4
Zhang, H1
Yang, T2
Dong, Y1
Xu, Y2
Yuan, Z1
Cao, J1
Zheng, Y1
Luo, Z1
Mei, Z1
Yao, Y1
Liu, Z2
Liang, C1
Yang, H1
Song, Y1
Yu, K1
Zhu, C1
Huang, Z1
Qian, J1
Ge, J1
Hu, J2
Wang, H2
Liu, Y4
Mi, Y1
Kong, H1
Xi, D1
Yan, W1
Luo, X1
Ning, Q1
Chang, X2
Zhang, T2
Rathore, MG1
Reddy, K1
Chen, H1
Shin, SH1
Ma, WY1
Bode, AM1
Dong, Z1
Mu, W1
Liu, C4
Gao, F1
Qi, Y1
Lu, H1
Zhang, X4
Cai, X1
Ji, RY1
Hou, Y3
Tian, J2
Shi, Y2
Ying, S1
Tan, M1
Feng, G1
Kuang, Y1
Chen, D1
Wu, D3
Zhu, ZQ1
Tang, HX1
Shi, ZE1
Kang, J1
Liu, Q1
Qi, J2
Mu, J1
Cong, Z1
Chen, S2
Fu, D1
Li, Z2
Celestrin, CP1
Rocha, GZ1
Stein, AM1
Guadagnini, D1
Tadelle, RM1
Saad, MJA1
Oliveira, AG1
Bianconi, V1
Bronzo, P1
Banach, M1
Sahebkar, A1
Mannarino, MR1
Pirro, M1
Patsourakos, NG1
Kouvari, M1
Kotidis, A1
Kalantzi, KI1
Tsoumani, ME1
Anastasiadis, F1
Andronikos, P1
Aslanidou, T1
Efraimidis, P1
Georgiopoulos, A1
Gerakiou, K1
Grigoriadou-Skouta, E1
Grigoropoulos, P1
Hatzopoulos, D1
Kartalis, A1
Lyras, A1
Markatos, G1
Mikrogeorgiou, A1
Myroforou, I1
Orkopoulos, A1
Pavlidis, P1
Petras, C1
Riga, M1
Skouloudi, M1
Smyrnioudis, N1
Thomaidis, K1
Tsikouri, GE1
Tsikouris, EI1
Zisimos, K1
Vavoulis, P1
Vitali, MG1
Vitsas, G1
Vogiatzidis, C1
Chantanis, S1
Fousas, S1
Panagiotakos, DB1
Tselepis, AD1
Jungen, C1
Alken, FA1
Eickholt, C1
Scherschel, K1
Kuklik, P1
Klatt, N1
Schwarzl, J1
Moser, J1
Jularic, M1
Akbulak, RO1
Schaeffer, B1
Willems, S1
Meyer, C1
Nowak, JK1
Szczepanik, M1
Trypuć, M1
Pogorzelski, A1
Bobkowski, W1
Grytczuk, M1
Minarowska, A1
Wójciak, R1
Walkowiak, J1
Lu, Y1
Xi, J1
Li, C1
Chen, W2
Hu, X1
Zhang, F1
Wei, H1
Gurzu, S1
Jung, I1
Sugimura, H2
Stefan-van Staden, RI1
Yamada, H1
Natsume, H1
Iwashita, Y1
Szodorai, R1
Szederjesi, J1
Yari, D1
Ehsanbakhsh, Z1
Validad, MH1
Langroudi, FH1
Esfandiari, H1
Prager, A1
Hassanpour, K1
Kurup, SP1
Mets-Halgrimson, R1
Yoon, H1
Zeid, JL1
Mets, MB1
Rahmani, B1
Araujo-Castillo, RV1
Culquichicón, C1
Solis Condor, R1
Efendi, F1
Sebayang, SK1
Astutik, E1
Hadisuyatmana, S1
Has, EMM1
Kuswanto, H1
Foroutan, T1
Ahmadi, F1
Moayer, F1
Khalvati, S1
Zhang, Q2
Lyu, Y1
Huang, J1
Yu, N1
Wen, Z1
Hou, H1
Zhao, T1
Gupta, A1
Khosla, N1
Govindasamy, V1
Saini, A1
Annapurna, K1
Dhakate, SR1
Akkaya, Ö1
Chandgude, AL1
Dömling, A1
Harnett, J1
Oakes, K1
Carè, J1
Leach, M1
Brown, D1
Cramer, H1
Pinder, TA1
Steel, A1
Anheyer, D1
Cantu, J1
Valle, J1
Flores, K1
Gonzalez, D1
Valdes, C1
Lopez, J1
Padilla, V1
Alcoutlabi, M1
Parsons, J1
Núñez, K1
Hamed, M1
Fort, D1
Bruce, D1
Thevenot, P1
Cohen, A1
Weber, P1
Menezes, AMB1
Gonçalves, H1
Perez-Padilla, R1
Jarvis, D1
de Oliveira, PD1
Wehrmeister, FC1
Mir, S1
Wong, J1
Ryan, CM1
Bellingham, G1
Singh, M2
Waseem, R1
Eckert, DJ1
Chung, F1
Hegde, H1
Shimpi, N1
Panny, A1
Glurich, I1
Christie, P1
Acharya, A1
English, KL1
Downs, M1
Goetchius, E1
Buxton, R1
Ryder, JW1
Ploutz-Snyder, R1
Guilliams, M1
Scott, JM1
Ploutz-Snyder, LL1
Martens, C1
Goplen, FK1
Aasen, T1
Gjestad, R1
Nordfalk, KF1
Nordahl, SHG1
Inoue, T1
Soshi, S1
Kubota, M1
Marumo, K1
Mortensen, NP1
Caffaro, MM1
Patel, PR2
Uddin, MJ1
Aravamudhan, S1
Sumner, SJ1
Fennell, TR1
Gal, RL1
Cohen, NJ1
Kruger, D1
Beck, RW1
Bergenstal, RM1
Calhoun, P1
Cushman, T1
Haban, A1
Hood, K1
Johnson, ML1
McArthur, T1
Olson, BA1
Weinstock, RS1
Oser, SM1
Oser, TK1
Bugielski, B1
Strayer, H1
Aleppo, G1
Maruyama, H1
Hirayama, K1
Yamashita, M1
Ohgi, K1
Tsujimoto, R1
Takayasu, M1
Shimohata, H1
Kobayashi, M1
Buscagan, TM1
Rees, DC1
Jaborek, JR1
Zerby, HN1
Wick, MP1
Fluharty, FL1
Moeller, SJ1
Razavi, P1
Dickler, MN1
Shah, PD1
Toy, W1
Brown, DN1
Won, HH1
Li, BT1
Shen, R1
Vasan, N1
Modi, S1
Jhaveri, K1
Caravella, BA1
Patil, S1
Selenica, P1
Zamora, S1
Cowan, AM1
Comen, E1
Singh, A1
Covey, A1
Berger, MF1
Hudis, CA1
Norton, L1
Nagy, RJ1
Odegaard, JI1
Lanman, RB1
Solit, DB1
Robson, ME1
Lacouture, ME1
Brogi, E1
Reis-Filho, JS1
Moynahan, ME1
Scaltriti, M1
Chandarlapaty, S1
Papouskova, K1
Moravcova, M1
Masrati, G1
Ben-Tal, N1
Sychrova, H1
Zimmermannova, O1
Fang, J1
Fan, Y1
Luo, T2
Su, H1
Tsetseris, L1
Anthopoulos, TD1
Liu, SF1
Zhao, K1
Sacan, O1
Turkyilmaz, IB1
Bayrak, BB1
Mutlu, O1
Akev, N1
Yanardag, R1
Gruber, S1
Kamnoedboon, P1
Özcan, M1
Srinivasan, M1
Jo, YH1
Oh, HK1
Jeong, SY1
Lee, BG1
Zheng, J1
Guan, H1
Li, D2
Tan, H1
Maji, TK1
J R, A1
Mukherjee, S1
Alexander, R1
Mondal, A1
Das, S1
Sharma, RK1
Chakraborty, NK1
Dasgupta, K1
Sharma, AMR1
Hawaldar, R1
Pandey, M1
Naik, A1
Majumdar, K1
Pal, SK1
Adarsh, KV1
Ray, SK1
Karmakar, D1
Ma, Y2
Gao, W1
Ma, S1
Lin, W1
Zhou, T1
Wu, T1
Wu, Q1
Ye, C1
He, X1
Jiang, F1
Yuan, D1
Chen, Q1
Hong, M1
Chen, K1
Hussain, M1
Razi, SS1
Yildiz, EA1
Zhao, J1
Yaglioglu, HG1
Donato, MD1
Jiang, J1
Jamil, MI1
Zhan, X1
Chen, F1
Cheng, D1
Wu, CT1
Utsunomiya, T1
Ichii, T1
Fujinami, S1
Nakajima, K1
Sanchez, DM1
Raucci, U1
Ferreras, KN1
Martínez, TJ1
Mordi, NA1
Mordi, IR1
Singh, JS1
McCrimmon, RJ1
Struthers, AD1
Lang, CC1
Wang, XW1
Yuan, LJ1
Yang, Y1
Chen, WF1
Luo, R1
Yang, K1
Amarasiri, SS1
Attanayake, AP1
Arawwawala, LDAM1
Jayatilaka, KAPW1
Mudduwa, LKB1
Ogunsuyi, O2
Akanni, O1
Alabi, O1
Alimba, C1
Adaramoye, O1
Cambier, S1
Eswara, S1
Gutleb, AC1
Bakare, A1
Gu, Z1
Cong, J1
Pellegrini, M1
Palmieri, S1
Ricci, A1
Serio, A1
Paparella, A1
Lo Sterzo, C1
Jadeja, SD1
Vaishnav, J1
Mansuri, MS1
Shah, C1
Mayatra, JM1
Shah, A1
Begum, R1
Song, H2
Lian, Y1
Wan, T1
Schultz-Lebahn, A1
Skipper, MT1
Hvas, AM1
Larsen, OH1
Hijazi, Z1
Granger, CB1
Hohnloser, SH1
Westerbergh, J1
Lindbäck, J1
Alexander, JH1
Keltai, M1
Parkhomenko, A1
López-Sendón, JL1
Lopes, RD1
Siegbahn, A1
Wallentin, L1
El-Tarabany, MS1
Saleh, AA1
El-Araby, IE1
El-Magd, MA1
van Ginkel, MPH1
Schijven, MP1
van Grevenstein, WMU1
Schreuder, HWR1
Pereira, EDM1
da Silva, J1
Carvalho, PDS1
Grivicich, I1
Picada, JN1
Salgado Júnior, IB1
Vasques, GJ1
Pereira, MADS1
Reginatto, FH1
Ferraz, ABF1
Vasilenko, EA1
Gorshkova, EN1
Astrakhantseva, IV1
Drutskaya, MS1
Tillib, SV1
Nedospasov, SA1
Mokhonov, VV1
Nam, YW1
Cui, M1
Orfali, R1
Viegas, A1
Nguyen, M1
Mohammed, EHM1
Zoghebi, KA1
Rahighi, S1
Parang, K1
Patterson, KC1
Kahanovitch, U1
Gonçalves, CM1
Hablitz, JJ1
Staruschenko, A1
Mulkey, DK1
Olsen, ML1
Gu, L1
Cao, X1
Mukhtar, A1
Wu, K1
Zhang, YY1
Zhu, Y1
Lu, DZ1
Dong, W1
Bi, WJ1
Feng, XJ1
Wen, LM1
Sun, H1
Qi, MC1
Chang, CC1
Dinh, TK1
Lee, YA1
Wang, FN1
Sung, YC1
Yu, PL1
Chiu, SC1
Shih, YC1
Wu, CY1
Huang, YD1
Lu, TT1
Wan, D1
Sakizadeh, J1
Cline, JP1
Snyder, MA1
Kiely, CJ1
McIntosh, S1
Jiang, X1
Cao, JW1
Zhao, CK1
Yang, R1
Zhang, QY1
Chen, KJ2
Liu, H1
He, Z1
Chen, B1
Wu, J1
Du, X1
Moore, J1
Blank, BR1
Eksterowicz, J1
Sutimantanapi, D1
Yuen, N1
Metzger, T1
Chan, B1
Huang, T1
Duong, F1
Kong, W1
Chang, JH1
Sun, J1
Zavorotinskaya, T1
Ye, Q1
Junttila, MR1
Ndubaku, C1
Friedman, LS1
Fantin, VR1
Sun, D1
Fei, P1
Xie, Q1
Feng, H1
Chang, Y1
Kang, H1
Xing, M1
Chen, J1
Shao, Z1
Yuan, C1
Wu, Y1
Allan, R1
Canham, K1
Wallace, R1
Singh, D1
Ward, J1
Cooper, A1
Newcomb, C1
Nammour, S1
El Mobadder, M1
Maalouf, E1
Namour, M1
Namour, A1
Rey, G1
Matamba, P1
Matys, J1
Zeinoun, T1
Grzech-Leśniak, K1
Segabinazi Peserico, C1
Garozi, L1
Zagatto, AM1
Machado, FA1
Hirth, JM1
Dinehart, EE1
Lin, YL1
Kuo, YF1
Nouri, SS1
Ritchie, C1
Volow, A1
Li, B2
McSpadden, S1
Dearman, K1
Kotwal, A1
Sudore, RL1
Ward, L1
Thakur, A1
Kondadasula, SV1
Ji, K1
Schalk, DL1
Bliemeister, E1
Ung, J1
Aboukameel, A1
Casarez, E1
Sloane, BF1
Lum, LG1
Xiao, M1
Feng, X1
Gao, R1
Du, B1
Brooks, T1
Zwirner, J1
Hammer, N1
Ondruschka, B1
Jermy, M1
Luengo, A1
Marzo, I1
Reback, M1
Daubit, IM1
Fernández-Moreira, V1
Metzler-Nolte, N1
Gimeno, MC1
Tonchev, I1
Heberman, D1
Peretz, A1
Medvedovsky, AT1
Gotsman, I1
Rashi, Y1
Poles, L1
Goland, S1
Perlman, GY1
Danenberg, HD1
Beeri, R1
Shuvy, M1
Fu, Q1
Yang, D1
Sarapulova, A1
Pang, Q1
Meng, Y1
Wei, L1
Ehrenberg, H1
Kim, CC1
Jeong, SH1
Oh, KH1
Nam, KT1
Sun, JY1
Ning, J1
Duan, Z1
Kershaw, SV1
Rogach, AL1
Gao, Z1
Wang, T1
Li, Q1
Cao, T1
Guo, L1
Fu, Y1
Seeger, ZL1
Izgorodina, EI1
Hue, S1
Beldi-Ferchiou, A1
Bendib, I1
Surenaud, M1
Fourati, S1
Frapard, T1
Rivoal, S1
Razazi, K1
Carteaux, G1
Delfau-Larue, MH1
Mekontso-Dessap, A1
Audureau, E1
de Prost, N1
Gao, SS1
Duangthip, D1
Lo, ECM1
Chu, CH1
Roberts, W1
Rosenheck, RA1
Miyake, T1
Kimoto, E1
Luo, L1
Mathialagan, S1
Horlbogen, LM1
Ramanathan, R1
Wood, LS1
Johnson, JG1
Le, VH1
Vourvahis, M1
Rodrigues, AD1
Muto, C1
Furihata, K1
Sugiyama, Y1
Kusuhara, H1
Gong, Q1
Song, W1
Sun, B1
Cao, P1
Gu, S1
Sun, X1
Zhou, G1
Toma, C1
Khandhar, S1
Zalewski, AM1
D'Auria, SJ1
Tu, TM1
Jaber, WA1
Cho, J2
Suwandaratne, NS1
Razek, S1
Choi, YH1
Piper, LFJ1
Watson, DF1
Banerjee, S1
Xie, S1
Lindsay, AP1
Bates, FS1
Lodge, TP1
Hao, Y1
Chapovetsky, A1
Liu, JJ1
Welborn, M1
Luna, JM1
Do, T1
Haiges, R1
Miller Iii, TF1
Marinescu, SC1
Lopez, SA1
Compter, I1
Eekers, DBP1
Hoeben, A1
Rouschop, KMA1
Reymen, B1
Ackermans, L1
Beckervordersantforth, J1
Bauer, NJC1
Anten, MM1
Wesseling, P1
Postma, AA1
De Ruysscher, D1
Lambin, P1
Qiang, L1
Yang, S1
Cui, YH1
He, YY1
Kumar, SK1
Jacobus, SJ1
Cohen, AD1
Weiss, M1
Callander, N1
Singh, AK1
Parker, TL1
Menter, A1
Parsons, B1
Kumar, P1
Kapoor, P1
Rosenberg, A1
Zonder, JA1
Faber, E1
Lonial, S1
Anderson, KC1
Richardson, PG1
Orlowski, RZ1
Wagner, LI1
Rajkumar, SV1
Li, G1
Hou, G1
Cui, J1
Xie, H1
Sun, Z1
Fang, Z1
Dunstand-Guzmán, E1
Hallal-Calleros, C1
Hernández-Velázquez, VM1
Canales-Vargas, EJ1
Domínguez-Roldan, R1
Pedernera, M1
Peña-Chora, G1
Flores-Pérez, I1
Kim, MJ1
Han, C1
White, K1
Park, HJ1
Ding, D1
Boyd, K1
Rothenberger, C1
Bose, U1
Carmichael, P1
Linser, PJ1
Tanokura, M1
Salvi, R1
Someya, S1
Samuni, A1
Goldstein, S1
Divya, KP1
Dharuman, V1
Feng, J2
Qian, Y1
Cheng, Q1
Ma, H1
Ren, X1
Wei, Q1
Pan, W1
Guo, J1
Situ, B1
An, T1
Zheng, L1
Augusto, S1
Ratola, N1
Tarín-Carrasco, P1
Jiménez-Guerrero, P1
Turco, M1
Schuhmacher, M1
Costa, S1
Teixeira, JP1
Costa, C2
Syed, A1
Marraiki, N1
Al-Rashed, S1
Elgorban, AM1
Yassin, MT1
Chankhanittha, T1
Nanan, S1
Sorokina, KN1
Samoylova, YV1
Gromov, NV1
Ogorodnikova, OL1
Parmon, VN1
Ye, J1
Zhang, P1
Nabi, M1
Cai, Y1
Li, F1
Alsbou, EM1
Omari, KW1
Adeosun, WA1
Asiri, AM1
Marwani, HM1
Barral, M1
Jemal-Turki, A1
Beuvon, F1
Soyer, P1
Camparo, P1
Cornud, F1
Atwater, BD1
Jones, WS1
Loring, Z1
Friedman, DJ1
Namburath, M1
Papirio, S1
Moscariello, C1
Di Costanzo, N1
Pirozzi, F1
Alappat, BJ1
Sreekrishnan, TR1
Volpin, F1
Woo, YC1
Kim, H1
Freguia, S1
Jeong, N1
Choi, JS1
Phuntsho, S1
Shon, HK1
Domínguez-Zambrano, E1
Pedraza-Chaverri, J1
López-Santos, AL1
Medina-Campos, ON1
Cruz-Rivera, C1
Bueno-Hernández, F1
Espinosa-Cuevas, A1
Bulavaitė, A1
Dalgediene, I1
Michailoviene, V1
Pleckaityte, M1
Sauerbier, P1
Köhler, R1
Renner, G1
Militz, H1
Elsayed, A1
M Abdelraheem, E1
Hassan, H1
Abbas, A1
Hassnine, A1
Qin, S1
Zhou, C1
Hamid, H1
Zhang, JY1
Li, WX1
Li, ML1
Zhao, LH1
Ji, C1
Ma, QG1
Fernández Rodríguez, CM1
Aller, R1
Gutiérrez García, ML1
Ampuero, J1
Gómez-Camarero, J1
Martín-Mateos, RMª1
Burgos-Santamaría, D1
Rosales, JM1
Aspichueta, P1
Buque, X1
Latorre, M1
Andrade, RJ1
Hernández-Guerra, M1
Romero-Gómez, M1
Lombardi, R1
Pisano, G1
Fargion, S1
Jaruvongvanich, V1
Ahuja, W1
Wijarnpreecha, K1
Ungprasert, P1
Watanabe, A1
Sohail, MA1
Gomes, DA1
Hashmi, A1
Nagata, J1
Sutterwala, FS1
Mahmood, S1
Jhandier, MN1
Flavell, RA1
Mehal, WZ1
Afzali, A1
Weiss, NS1
Boyko, EJ1
Ioannou, GN1
Isselbacher, KJ1
Greenberger, NJ1
ALVSAKER, JO1
Pellicano, R1
Puglisi, G1
Ciancio, A1
Balzola, F1
Saracco, G1
Ciccone, G1
Baldi, I1
Abate, ML1
Smedile, A1
Rizzetto, M1
Lundvall, O1
Berlind, S1
Bufalari, A1
Meloni, G1
Rodríguez Pérez, A2
González San Martín, F2
Alonso Gutiérrez, D2
Cabades O'Callaghan, F1
de Portugal Alvarez, J2
Rodrigo Rodríguez, M1
Decaux, G6
Mols, P1
Naeije, R1
Reding, P1
Luft, D1
Egberts, EH1
Rittershofer, H1
Müller, PH1
Schmülling, R1
Prestele, H1
Horbach, L1
Malchow, H1
Higuchi, T2
Nakamura, T2
Uchino, H2
Usami, M1
Furuchi, K1
Kasahara, H1
Haji, S1
Kitani, G1
Iso, A1
Sun, K1
Sou, E1
Zheng, JH1
Sakata, K1
Pelatti, A1
Quaratino, CP1
D'Amario, C1
Tentarelli, R1
Sforza, GR1
Giacomello, A1
Schlesser, M2
Coffernils, M1
Prospert, F2
Namias, B2
Brimioulle, S1
Soupart, A2
Loguercio, C2
Nardone, G2
Sicolo, P2
Cuomo, R1
Del Vecchio, C1
Budillon, G2
Walter-Sack, I1
de Vries, JX1
von Bubnoff, A1
Pfleilschifter, V1
Raedsch, R1
Yamamoto, Y1
Yamashita, S1
Lee, WC1
Lin, HC1
Hou, MC1
Lin, HY1
Lee, FY1
Wang, SS1
Chang, FY1
Lee, SD1
Latorzeff, S1
Pujol, M1
Arlet, J1
Zotti, S1
Dagnini, G1
Abrahamsohn, C1
de Nadai Frank, A1
Sandri, R1
Weiss, V1
Lomessy, A1
Reynolds, TB1
Lieberman, FL1
Goodman, AR1
Brodan, V1
Brodanová, M1
Kuhn, E1
Filip, J1
Pechar, J1
Eastlund, DT1
Citarella, C1
Del Vecchio Blanco, C1
Scott, NR1
Stambuk, D1
Chakraborty, J1
Marks, V1
Morgan, MY1
Nanji, AA1
French, SW1
Hanson, B1
Cauchie, P1
Bosson, D1
Unger, J1
Pupita, F1
Campolucci, G1
Pulido, M1
Belogi, M1
Rotatori, P1
Ansuini, R1
Frausini, G1
Barone, A1
Gaggi, S1
Loginov, AS1
Dzhalalov, KD1
Blok, IuE1
Lechat, S1
Pattin, S1
Vigne, J1
Ferris, TF1
Gorden, P1
Sinclair, HM1
Lieber, CS1
Schlosstein, L1
Kippen, I1
Bluestone, R1
Whitehouse, MW1
Klinenberg, JR1
Michelis, MF1
Warms, PC1
Fusco, RD1
Davis, BB1
Starzl, TE1
Putnam, CW1
Porter, KA1
Halgrimson, CG1
Corman, J1
Brown, BI1
Gotlin, RW1
Rodgerson, DO1
Greene, HL1
Grams, RR1
Johnson, EA1
Benson, ES1
Amerio, A1
Mastrangelo, F1
Pastore, G1
Bhambal, SA1
Sharma, KS1
Bhambal, S1
Curri, SB1
Leiter, L1
Anderton, JL1
Kincaid-Smith, P1
Cordova, C1
Doliopoulos, T1
Liaskou, F1
Marousis, S1
Yoshida, T1
Konno, T1
Arakawa, T1
Leu, ML1
Strickland, GT1
Gutman, RA1
Zucchelli, P1
Petrella, A1
Fusaroli, M1
Sasdelli, M1
Melica, A1
Shear, L1
Bonkowsky, HL1
Gabuzda, GJ1
Lavicka, J1
Chaloupková, E1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparative Study Evaluating the Outcome of Febuxostat Versus Vitamin E in Hyperuricemia Patients With Non-alcoholic Steatohepatitis Without Cirrhosis[NCT05574036]Phase 270 participants (Anticipated)Interventional2022-08-25Recruiting
Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Egyptian Cirrhotic Patients With Ascites[NCT04785755]Phase 290 participants (Actual)Interventional2017-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

8 reviews available for uric acid and Cirrhosis, Liver

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD.
    International journal of molecular sciences, 2016, Apr-12, Volume: 17, Issue:4

    Topics: Disease Progression; Ferritins; Humans; Liver Cirrhosis; Metabolic Syndrome; Non-alcoholic Fatty Liv

2016
Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:6

    Topics: Biomarkers; Chi-Square Distribution; Humans; Hyperuricemia; Liver Cirrhosis; Non-alcoholic Fatty Liv

2017
METABOLIC EFFECTS OF ALCOHOL ON THE LIVER.
    The New England journal of medicine, 1964, 02-20, Volume: 270

    Topics: Alcoholism; Carbohydrate Metabolism; Catecholamines; Ethanol; Fatty Liver; Folic Acid; Gastrointesti

1964
Nutritional aspects of alcohol consumption.
    The Proceedings of the Nutrition Society, 1972, Volume: 31, Issue:2

    Topics: Alcoholism; Animals; Cholecalciferol; Choline Deficiency; Ethanol; Fatty Liver; Glutamates; Humans;

1972
Metabolic effects produced by alcohol in the liver and other tissues.
    Advances in internal medicine, 1968, Volume: 14

    Topics: Acetaldehyde; Acetates; Alcoholism; Coenzymes; Deficiency Diseases; Dietary Carbohydrates; Enzymes;

1968
Combinations of diuretics in the treatment of edema.
    American heart journal, 1970, Volume: 80, Issue:3

    Topics: Acetazolamide; Benzothiadiazines; Chlorthalidone; Diuretics; Edema; Ethacrynic Acid; Furosemide; Glu

1970
Diuretics. II. Clinical considerations.
    Drugs, 1971, Volume: 1, Issue:2

    Topics: Administration, Oral; Aminophylline; Ascites; Calcium; Carbohydrate Metabolism; Carbonic Anhydrase I

1971

Trials

7 trials available for uric acid and Cirrhosis, Liver

ArticleYear
Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: A randomized, double-blind, placebo-controlled trial.
    Diabetes, obesity & metabolism, 2020, Volume: 22, Issue:11

    Topics: Adult; Elasticity Imaging Techniques; Humans; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Dise

2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Serum uric acid levels in patients with cirrhosis: a reevaluation.
    Journal of clinical gastroenterology, 1999, Volume: 29, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Hemodynamics; Humans; Kidney Function Tests; Liv

1999
Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
    The Journal of laboratory and clinical medicine, 2001, Volume: 138, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Diuresis; Humans; Hyponatremia; Ina

2001
[Depletive treatment of uncompensated liver cirrhosis with high doses of spirolactone only].
    Minerva medica, 1977, Feb-11, Volume: 68, Issue:7

    Topics: Adult; Aged; Bilirubin; Clinical Trials as Topic; Female; Humans; Liver Cirrhosis; Male; Middle Aged

1977
Advantages of treatment of ascites without sodium restriction and without complete removal of excess fluid.
    Gut, 1978, Volume: 19, Issue:6

    Topics: Blood Urea Nitrogen; Brain Diseases; Creatinine; Diuresis; Humans; Liver Cirrhosis; Random Allocatio

1978
Ammonia and uric acid formation after rapid intravenous fructose administration to healthy subjects and patients with compensated cirrhosis of the liver.
    Nutrition and metabolism, 1975, Volume: 19, Issue:5-6

    Topics: Adult; Ammonia; Clinical Trials as Topic; Female; Fructose; Humans; Injections, Intravenous; Liver;

1975

Other Studies

61 other studies available for uric acid and Cirrhosis, Liver

ArticleYear
Improvement in hepatic fibrosis estimated by Fibrosis-4 index in pegloticase treated chronic refractory gout patients.
    Clinical and experimental rheumatology, 2023, Volume: 41, Issue:1

    Topics: Chronic Disease; Gout; Gout Suppressants; Humans; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease

2023
Associations of Uric Acid With Liver Steatosis and Fibrosis Applying Vibration Controlled Transient Elastography in the United States: A Nationwide Cross-Section Study.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Cross-Sectional Studies; Elasticity Imaging Techniques; Fatty Liver; Female; Humans; Liver Cirrhosis

2022
Theacrine ameliorates experimental liver fibrosis in rats by lowering cholesterol storage via activation of the Sirtuin 3-farnesoid X receptor signaling pathway.
    Chemico-biological interactions, 2022, Sep-01, Volume: 364

    Topics: Animals; beta Catenin; Cholesterol; Liver; Liver Cirrhosis; Mice; Rats; Signal Transduction; Sirtuin

2022
[Clinical significance of ultrasound combined with serological indexes for predicting nonalcoholic fatty liver disease in patients with chronic hepatitis B with normal or slightly elevated alanine aminotransferase].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2022, Nov-20, Volume: 30, Issue:11

    Topics: Alanine Transaminase; Biopsy; Clinical Relevance; Hepatitis B, Chronic; Humans; Liver; Liver Cirrhos

2022
Prevalence and Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease with Renal Insufficiency in Overweight/Obese Adults.
    Obesity facts, 2023, Volume: 16, Issue:6

    Topics: Adult; Female; Humans; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Obesity; Overweight

2023
FIB-4 is closer to FibroScan screen results to detecting advanced liver fibrosis and maybe facilitates NAFLD warning.
    Medicine, 2023, Aug-25, Volume: 102, Issue:34

    Topics: Cross-Sectional Studies; Elasticity Imaging Techniques; Humans; Liver Cirrhosis; Metabolic Syndrome;

2023
Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort study.
    Obesity (Silver Spring, Md.), 2023, Volume: 31, Issue:12

    Topics: Diabetes Mellitus, Type 2; Female; Humans; Liver; Liver Cirrhosis; Male; Menopause; Middle Aged; Non

2023
Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents.
    Journal of gastroenterology and hepatology, 2020, Volume: 35, Issue:3

    Topics: Aged; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Hyperuricemia; Liver Cirrhosis; Male;

2020
Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality.
    Digestive diseases and sciences, 2020, Volume: 65, Issue:9

    Topics: Adult; Body Mass Index; Elasticity Imaging Techniques; Fatty Liver; Female; Humans; Hyperuricemia; L

2020
Uric acid induces liver fibrosis through activation of inflammatory mediators and proliferating hepatic stellate cell in mice.
    The Medical journal of Malaysia, 2020, Volume: 75, Issue:Suppl 1

    Topics: Animals; Hepatic Stellate Cells; Liver Cirrhosis; Mice; Uric Acid

2020
Efficacy of antiviral therapy in patients with post-hepatitis C liver cirrhosis: is hyperuricaemia a potential adverse effect?
    BMJ open gastroenterology, 2020, Volume: 7, Issue:1

    Topics: Antiviral Agents; Child; Hepacivirus; Hepatitis C; Humans; Hyperuricemia; Liver Cirrhosis; Prospecti

2020
The severity of NAFLD is associated with the risk of urolithiasis.
    British journal of biomedical science, 2019, Volume: 76, Issue:2

    Topics: Aged; Alcohol Drinking; Aspartate Aminotransferases; Blood Platelets; China; Electronic Health Recor

2019
Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model.
    Poultry science, 2019, Jun-01, Volume: 98, Issue:6

    Topics: Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bacteria; Cecum; Chickens; Disease Model

2019
Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD).
    Revista espanola de enfermedades digestivas, 2019, Volume: 111, Issue:4

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Body Mass Index; Chol

2019
Inflammasome-mediated regulation of hepatic stellate cells.
    American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 296, Issue:6

    Topics: Actins; Animals; Apoptosis Regulatory Proteins; Calcium Signaling; Carbon Tetrachloride; CARD Signal

2009
Association between serum uric acid level and chronic liver disease in the United States.
    Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:2

    Topics: Adult; Aged; Alanine Transaminase; Chronic Disease; Cross-Sectional Studies; Female; gamma-Glutamylt

2010
URIC ACID IN HUMAN PLASMA. I. INVESTIGATIONS ON THE PRESENCE OF PURINES IN HUMAN BLOOD.
    Scandinavian journal of clinical and laboratory investigation, 1965, Volume: 17

    Topics: Blood; Colorimetry; Gout; Humans; Hypoxanthines; Leukemia; Liver Cirrhosis; Oxidoreductases; Purines

1965
Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?
    Journal of medical virology, 2008, Volume: 80, Issue:4

    Topics: Adult; Aged; Antiviral Agents; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver

2008
Clinical trial of a potassium-sparing saluretic pyrazine derivative (MK-870).
    Acta medica Scandinavica, 1967, Volume: 181, Issue:4

    Topics: Adult; Aged; Carbon Dioxide; Chlorides; Creatine; Diuretics; Edema; Female; Heart Failure; Humans; L

1967
[The behavior of uricemia during treatment with spironolactone and with other diuretics].
    Minerva medica, 1967, Nov-07, Volume: 58, Issue:89

    Topics: Acetazolamide; Adolescent; Adult; Aged; Chlorthalidone; Clopamide; Diuretics; Ethacrynic Acid; Femal

1967
[Metabolism of uric acid in cirrhosis patients].
    Revista espanola de las enfermedades del aparato digestivo, 1984, Volume: 65, Issue:5

    Topics: Humans; Kidney; Liver; Liver Cirrhosis; Purines; Uric Acid

1984
[Metabolism of uric acid in cirrhosis patients (second part)].
    Revista espanola de las enfermedades del aparato digestivo, 1984, Volume: 65, Issue:6

    Topics: Humans; Liver Cirrhosis; Uric Acid

1984
Hypouricemia in cirrhosis reflects hemodynamic alterations.
    Metabolism: clinical and experimental, 1984, Volume: 33, Issue:8

    Topics: Bilirubin; Cardiac Output; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Liver Cirrhosis

1984
[Carbohydrate infusion in internal diseases. A comparative study in metabolically healthy patients, patients with liver diseases and diabetic patients. I. Physiopathologic aspects in the parenteral administration of monosaccharides].
    Infusionstherapie und klinische Ernahrung, 1981, Volume: 8, Issue:4

    Topics: Blood Glucose; Diabetes Mellitus; Fructose; Humans; Liver Cirrhosis; Monosaccharides; Parenteral Nut

1981
[Carbohydrate infusion in internal diseases. A comparative study in metabolically healthy, liver diseased and diabetic patients. VI. Infusions of a glucose/xylitol mixture (1:1 ratio) over a 48-hour period].
    Infusionstherapie und klinische Ernahrung, 1982, Volume: 9, Issue:2

    Topics: Blood Glucose; Diabetes Mellitus; Fatty Acids, Nonesterified; Glucose; Glucose Solution, Hypertonic;

1982
Enhanced renal clearance of uric acid in hepatic cirrhosis.
    Israel journal of medical sciences, 1981, Volume: 17, Issue:11

    Topics: Adult; Aged; Hepatitis; Humans; Kidney; Liver; Liver Cirrhosis; Male; Middle Aged; Testosterone; Uri

1981
[Uric acid metabolism in patients with liver disease (author's transl)].
    Ryumachi. [Rheumatism], 1980, Volume: 20, Issue:5

    Topics: Adult; Chronic Disease; Creatinine; Hepatitis; Humans; Liver Cirrhosis; Male; Middle Aged; Testoster

1980
The effect of partial hepatectomy on blood purine levels in rats and patients.
    Advances in experimental medicine and biology, 1994, Volume: 370

    Topics: Adenosine Triphosphate; Animals; Chromatography, High Pressure Liquid; DNA; Hemangioma; Hepatectomy;

1994
Hypouricemia and an increased clearance of uric acid are observed in liver diseases?
    Advances in experimental medicine and biology, 1994, Volume: 370

    Topics: Acute Disease; Alanine Transaminase; Bilirubin; Biomarkers; Chronic Disease; Creatinine; Female; Hep

1994
Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia.
    Clinical nephrology, 1994, Volume: 42, Issue:2

    Topics: Acid-Base Equilibrium; Diuretics; Heart Failure; Humans; Hyponatremia; Hypopituitarism; Inappropriat

1994
Intravenous load of fructose and fructose 1,6-diphosphate: effects on uricemia in patients with nonalcoholic liver disease.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:3

    Topics: Adult; Carcinoma, Hepatocellular; Diagnosis, Differential; Female; Fructose; Fructose-Bisphosphatase

1996
Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?
    European journal of medical research, 1995, Oct-16, Volume: 1, Issue:1

    Topics: Adult; Benzbromarone; Female; Humans; Liver Cirrhosis; Middle Aged; Uric Acid; Uricosuric Agents

1995
Plasma ubiquinone to ubiquinol ratio in patients with hepatitis, cirrhosis, and hepatoma, and in patients treated with percutaneous transluminal coronary reperfusion.
    BioFactors (Oxford, England), 1999, Volume: 9, Issue:2-4

    Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Ascorbic Acid; beta Carotene; Biliru

1999
Uric acid level in cirrhosis.
    Journal of clinical gastroenterology, 2000, Volume: 30, Issue:4

    Topics: Creatinine; Female; Hemodynamics; Humans; Liver Cirrhosis; Male; Middle Aged; Uric Acid

2000
[Osteomalacia of complex etiology revealing a distal tubulopathy in an adult].
    Revue du rhumatisme et des maladies osteo-articulaires, 1975, Volume: 42, Issue:1

    Topics: Acidosis, Renal Tubular; Adult; Alkalies; Alkalosis; Bicarbonates; Calcium; Humans; Hydrogen-Ion Con

1975
[Alcoholism and anesthesia problems].
    Revue medicale de la Suisse romande, 1979, Volume: 99, Issue:1

    Topics: Alcoholism; Anesthesia; Brain; Ethanol; Fatty Liver; Humans; Lactates; Liver; Liver Cirrhosis; Uric

1979
Renal tubular dysfunction and cirrhosis.
    Archives of internal medicine, 1975, Volume: 135, Issue:5

    Topics: Humans; Kidney Tubules; Liver Cirrhosis; Uric Acid

1975
Hyperuricemia induced by fructose load in liver cirrhosis.
    The Italian journal of gastroenterology, 1992, Volume: 24, Issue:7

    Topics: Adult; Female; Fructose; Galactose; Humans; Infusions, Intravenous; Liver Cirrhosis; Liver Function

1992
Raised urea clearance in cirrhotic patients with high uric acid clearance is related to low salt excretion.
    Gut, 1992, Volume: 33, Issue:8

    Topics: Adult; Aged; Ascites; Blood Volume; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Middle Aged

1992
Caffeine clearance and biotransformation in patients with chronic liver disease.
    Clinical science (London, England : 1979), 1988, Volume: 74, Issue:4

    Topics: Adult; Aged; Biotransformation; Caffeine; Chronic Disease; Female; Humans; Liver Cirrhosis; Male; Mi

1988
Correlations between deviations from expected cirrhosis mortality and serum uric acid and dietary protein intake.
    Journal of studies on alcohol, 1986, Volume: 47, Issue:3

    Topics: Adult; Australia; Canada; Dietary Proteins; Europe; Humans; Israel; Japan; Liver Cirrhosis; Male; Mi

1986
Relationship between aldosterone and sodium, potassium, and uric acid clearance in cirrhosis with and without ascites.
    Nephron, 1986, Volume: 44, Issue:3

    Topics: Adult; Aldosterone; Ascitic Fluid; Female; Humans; Kinetics; Liver Cirrhosis; Male; Metabolic Cleara

1986
[Negative effects of diuretics].
    La Clinica terapeutica, 1985, Oct-15, Volume: 115, Issue:1

    Topics: Alkalosis; Diuretics; Heart Diseases; Humans; Hyperglycemia; Hypokalemia; Hyponatremia; Insulin; Liv

1985
[Diagnostic significance of determining the blood content of lactic and uric acids in chronic liver lesions of alcoholic and viral etiologies].
    Terapevticheskii arkhiv, 1985, Volume: 57, Issue:9

    Topics: Adult; Chronic Disease; Female; Hepatitis, Alcoholic; Hepatitis, Chronic; Humans; Lactates; Lactic A

1985
[Urinary tract infection, hyperuricemia, septicemia, transitory abdominal pain, cerebral accident].
    Harefuah, 1970, Feb-01, Volume: 78, Issue:3

    Topics: Aged; Ascites; Cerebrovascular Disorders; Cystitis; Hemiplegia; Humans; Liver Cirrhosis; Male; Prost

1970
[Value of an orotic acid-sorbitol combination in hepato-intestinal diseases. Point of view of a general practitioner].
    Revue des corps de sante des armees terre, mer, air, 1967, Volume: 8, Issue:2

    Topics: Adult; Aged; Alcoholism; Dyspepsia; Female; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Male

1967
Effect of angiotensin and norepinephrine upon urate clearance in man.
    The American journal of medicine, 1968, Volume: 44, Issue:3

    Topics: Adolescent; Adult; Angiotensin II; Diuresis; Glomerular Filtration Rate; Humans; Hypertension, Porta

1968
Association between hypouricaemia and jaundice.
    Annals of the rheumatic diseases, 1974, Volume: 33, Issue:4

    Topics: Adult; Aged; Alkaline Phosphatase; Animals; Female; Hepatitis; Humans; Hyperbilirubinemia; Jaundice;

1974
Hypouricemia and hyperuricosuria in Laennec cirrhosis.
    Archives of internal medicine, 1974, Volume: 134, Issue:4

    Topics: Alcoholism; Bilirubin; Creatinine; Fatty Liver; Humans; Kidney Function Tests; Kidney Tubules; Liver

1974
Portal diversion for the treatment of glycogen storage disease in humans.
    Annals of surgery, 1973, Volume: 178, Issue:4

    Topics: Acidosis; Biopsy; Blood Glucose; Child; Glycogen Storage Disease; Humans; Liver; Liver Cirrhosis; Li

1973
Laboratory data analysis system. IV. Multivariate diagnosis.
    American journal of clinical pathology, 1972, Volume: 58, Issue:2

    Topics: Aspartate Aminotransferases; Bilirubin; Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Cholecys

1972
[Reinfusion of desalinated and concentrated ascitic fluid in the treatment of decompensated liver cirrhosis].
    Schweizerische medizinische Wochenschrift, 1972, Dec-09, Volume: 102, Issue:49

    Topics: Ascitic Fluid; Dialysis; Electrophoresis; Glucose; Hemodynamics; Humans; Injections, Intravenous; Li

1972
Relationship between short duration and 24-hour urinary excretion pattern of some nitrogenous compounds.
    The Journal of the Association of Physicians of India, 1972, Volume: 20, Issue:10

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Creatine; Creatinine; Hepatitis A; Humans; Liver C

1972
The diagnostic significance of the finger-tip biopsy in microangiopathies. Pathology of the arteriovenous anastomoses and preterminal circulation.
    Bibliotheca anatomica, 1973, Volume: 11

    Topics: Adult; Arteriovenous Anastomosis; Biopsy; Cells, Cultured; Connective Tissue; Diabetic Angiopathies;

1973
[On the clinical and metabolic effects of mefruside].
    La Clinica terapeutica, 1971, Volume: 58, Issue:5

    Topics: Adult; Aged; Ascites; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus; Diuresis; Diuretics

1971
Comparison of the action of two new oral diuretics, the 4-chloro-N-methyl-3-(methylsulfamoly) benzamide and 4-chloro-3-sulfamylbenzoic acid 2,2-dimethylhydrazide (a study on 102 patients).
    Acta cardiologica, 1968, Volume: 23, Issue:5

    Topics: Adult; Aged; Arteries; Blood Glucose; Blood Pressure; Body Weight; Diuretics; Edema; Heart Failure;

1968
Hypocupremic infant associated with mental retardation and hepatic cirrhosis: probably a copper malabsorption syndrome.
    The Tohoku journal of experimental medicine, 1969, Volume: 98, Issue:3

    Topics: Amino Acids; Blood Glucose; Blood Proteins; Ceruloplasmin; Cholesterol; Copper; Electrolytes; Electr

1969
Renal function in Wilson's disease: response to penicillamine therapy.
    The American journal of the medical sciences, 1970, Volume: 260, Issue:6

    Topics: Adolescent; Adult; Aminohippuric Acids; Ammonium Chloride; Calcium; Dehydration; Female; Follow-Up S

1970
[Ethacrynic acid: research on the mechanism of action and clinical use].
    Minerva medica, 1968, Jan-17, Volume: 59, Issue:5

    Topics: Adolescent; Adult; Aged; Child; Diabetes Insipidus; Diuresis; Edema; Ethacrynic Acid; Female; Heart

1968
Renal tubular acidosis in cirrhosis. A determinant of susceptibility to recurrent hepatic precoma.
    The New England journal of medicine, 1969, Jan-02, Volume: 280, Issue:1

    Topics: Acidosis, Renal Tubular; Ammonia; Ammonium Chloride; Blood Urea Nitrogen; Calcium; Calcium Chloride;

1969
[Hyperuricemia in internal diseases].
    Fysiatricky a reumatologicky vestnik, 1969, Volume: 47, Issue:2

    Topics: Anemia; Cardiovascular Diseases; Gout; Hematologic Diseases; Humans; Hydrochlorothiazide; Kidney Dis

1969